Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children.

Vajo Z, Kosa L, Szilvasy I, Pauliny Z, Bartha K, Visontay I, Kis A, Tarjan I, Rozsa N, Jankovics I.

Pediatr Infect Dis J. 2008 Dec;27(12):1052-6. doi: 10.1097/INF.0b013e3181861dd7.

PMID:
18978514
3.

Influenza A (H5N1) pandemic prototype vaccine Fluval.

Vajo Z.

Expert Rev Vaccines. 2009 May;8(5):619-24. doi: 10.1586/erv.09.25. Review.

PMID:
19397418
4.

Current status and progress of prepandemic and pandemic influenza vaccine development.

Leroux-Roels I, Leroux-Roels G.

Expert Rev Vaccines. 2009 Apr;8(4):401-23. doi: 10.1586/erv.09.15. Review.

PMID:
19348557
5.

A/H5N1 prepandemic influenza vaccine (whole virion, vero cell-derived, inactivated) [Vepacel®].

Plosker GL.

Drugs. 2012 Jul 30;72(11):1543-57. doi: 10.2165/11209650-000000000-00000. Review.

PMID:
22788239
6.

Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly.

Curran MP, Leroux-Roels I.

Drugs. 2010 Aug 20;70(12):1519-43. doi: 10.2165/11205020-000000000-00000. Review.

PMID:
20687619
7.

Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature.

Prieto-Lara E, Llanos-Méndez A.

Vaccine. 2010 Jun 11;28(26):4328-34. doi: 10.1016/j.vaccine.2010.03.068. Epub 2010 Apr 18. Review.

PMID:
20403350
8.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
9.

Adjuvants for pandemic influenza vaccines.

Atmar RL, Keitel WA.

Curr Top Microbiol Immunol. 2009;333:323-44. doi: 10.1007/978-3-540-92165-3_16. Review.

PMID:
19768413
10.

The use of inactivated influenza vaccine in children.

Wright PF.

Semin Pediatr Infect Dis. 2006 Oct;17(4):200-5. Review.

PMID:
17055371
11.

Designing vaccines for pandemic influenza.

Horimoto T, Kawaoka Y.

Curr Top Microbiol Immunol. 2009;333:165-76. doi: 10.1007/978-3-540-92165-3_8. Review.

PMID:
19768405
12.

Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data.

Leroux-Roels G.

Expert Opin Biol Ther. 2009 Aug;9(8):1057-71. doi: 10.1517/14712590903066695. Review.

PMID:
19555313
13.

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Cinatl J Jr, Michaelis M, Doerr HW.

Med Microbiol Immunol. 2007 Dec;196(4):213-25. Epub 2007 Jun 1. Review.

PMID:
17541633
14.

Influenza vaccines in children.

Neuzil KM, Edwards KM.

Semin Pediatr Infect Dis. 2002 Jul;13(3):174-81. Review.

PMID:
12199613
15.

Vaccines against epidemic and pandemic influenza.

Hoelscher M, Gangappa S, Zhong W, Jayashankar L, Sambhara S.

Expert Opin Drug Deliv. 2008 Oct;5(10):1139-57. doi: 10.1517/17425247.5.10.1139 . Review. Erratum in: Expert Opin Drug Deliv. 2009 Feb;6(2):209.

PMID:
18817518
16.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
17.

A/H5N1 prepandemic influenza vaccine (Vepacel®): a guide to its use.

Keating GM, Plosker GL, Lyseng-Williamson KA.

BioDrugs. 2012 Dec 1;26(6):425-30. doi: 10.2165/11209740-000000000-00000. Review.

PMID:
23106407
18.

Inactivated influenza virus vaccines in children.

Ruben FL.

Clin Infect Dis. 2004 Mar 1;38(5):678-88. Epub 2004 Feb 17. Review.

19.

Emulsion-based adjuvants for influenza vaccines.

Vogel FR, Caillet C, Kusters IC, Haensler J.

Expert Rev Vaccines. 2009 Apr;8(4):483-92. doi: 10.1586/erv.09.5. Review.

PMID:
19348563
20.

Development and application of avian influenza vaccines in China.

Chen H, Bu Z.

Curr Top Microbiol Immunol. 2009;333:153-62. doi: 10.1007/978-3-540-92165-3_7. Review.

PMID:
19768404
Items per page

Supplemental Content

Write to the Help Desk